Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Other Operating Expenses (2020 - 2025)

Journey Medical (DERM) has disclosed Other Operating Expenses for 6 consecutive years, with $6.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses rose 29.03% year-over-year to $6.8 million, compared with a TTM value of $19.8 million through Sep 2025, down 19.76%, and an annual FY2024 reading of $19.8 million, down 33.73% over the prior year.
  • Other Operating Expenses was $6.8 million for Q3 2025 at Journey Medical, up from $6.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $21.3 million in Q2 2021 and bottomed at $1.1 million in Q4 2024.
  • Average Other Operating Expenses over 5 years is $8.1 million, with a median of $6.8 million recorded in 2024.
  • The sharpest move saw Other Operating Expenses skyrocketed 515.06% in 2021, then plummeted 81.58% in 2024.
  • Year by year, Other Operating Expenses stood at $9.5 million in 2021, then decreased by 18.97% to $7.7 million in 2022, then decreased by 22.07% to $6.0 million in 2023, then tumbled by 81.58% to $1.1 million in 2024, then surged by 515.43% to $6.8 million in 2025.
  • Business Quant data shows Other Operating Expenses for DERM at $6.8 million in Q3 2025, $6.0 million in Q2 2025, and $5.9 million in Q1 2025.